the major active component of Salvia divinorum, has resulted in the synthesis of novel neoclerodane diterpenes with opioid receptor affinity and activity. We report in this study that oxadiazole 11a and salvidivin A (12a), a photooxygenation product of 1a, have been identified as the first neoclerodane diterpenes with kappa antagonist activity. This indicates that additional structural modifications
Salvinorin A(1a)(Salvia divinorum的主要活性成分)的进一步修饰导致合成了具有阿片受体亲和力和活性的新型新
环戊烷二萜。我们在这项研究中报告说,已将恶二唑11a和Salvidivin A(12a)(1a的光氧合产物)确定为具有kappa拮抗剂活性的第一个新
环戊烷二萜。这表明1a的其他结构修饰可能会导致类似物具有更高的效力和作为滥用药物的效用。